Literature DB >> 1577899

Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children.

I Engström1.   

Abstract

Psychiatric disorders and behaviour problems were found to be commoner in children and adolescents with inflammatory bowel disease (IBD) than in matched comparison groups with tension headache and diabetes as well as in healthy children. Depression, anxiety and low self-esteem were common. Many children denied their problems. This may be due to the type of illness, its social consequences and the embarrassment experienced by the children. Discrepancies were found between the children's and their mothers' replies. These results are discussed in terms of their implication for paediatric practice.

Entities:  

Mesh:

Year:  1992        PMID: 1577899     DOI: 10.1111/j.1469-7610.1992.tb00891.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  34 in total

1.  Coping strategies and quality of life of adolescents with inflammatory bowel disease.

Authors:  H J van der Zaag-Loonen; M A Grootenhuis; B F Last; H H F Derkx
Journal:  Qual Life Res       Date:  2004-06       Impact factor: 4.147

2.  Using the Children's Depression Inventory in youth with inflammatory bowel disease: support for a physical illness-related factor.

Authors:  Rachel D Thompson; Anna E Craig; Christine Mrakotsky; Athos Bousvaros; David R DeMaso; Eva Szigethy
Journal:  Compr Psychiatry       Date:  2012-06-06       Impact factor: 3.735

3.  Behavioral Functioning and Treatment Adherence in Pediatric Inflammatory Bowel Disease: Review and Recommendations for Practice.

Authors:  Kevin A Hommel; Lee A Denson; Wallace V Crandall; Laura M Mackner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-11-01

4.  Assessing psychosocial risk in pediatric inflammatory bowel disease: validation of the Psychosocial Assessment Tool 2.0_General.

Authors:  Ahna L H Pai; Alayna Tackett; Elizabeth A Hente; Michelle M Ernst; Lee A Denson; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-01       Impact factor: 2.839

5.  Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?

Authors:  Rebekka Mueller; Farah Ziade; Valérie Pittet; Nicolas Fournier; Jessica Ezri; Alain Schoepfer; Susanne Schibli; Johannes Spalinger; Christian Braegger; Andreas Nydegger
Journal:  J Crohns Colitis       Date:  2015-10-29       Impact factor: 9.071

Review 6.  Children with diabetes compared to peers: depressed? Distressed? A meta-analytic review.

Authors:  Kerry A Reynolds; Vicki S Helgeson
Journal:  Ann Behav Med       Date:  2011-08

7.  Stability of Emotional and Behavioral Functioning in Youth with Inflammatory Bowel Disease.

Authors:  Bonney Reed-Knight; Debra Lobato; Sarah Hagin; Elizabeth L McQuaid; Ronald Seifer; Sheryl J Kopel; Julie Boergers; Jack H Nassau; Kristina Suorsa; Barbara Bancroft; Neal S LeLeiko
Journal:  Child Health Care       Date:  2013-10-22

8.  Correlates of depression in new onset pediatric inflammatory bowel disease.

Authors:  P M Burke; D Neigut; S Kocoshis; R Chandra; J Sauer
Journal:  Child Psychiatry Hum Dev       Date:  1994

9.  Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease.

Authors:  David Benhayon; Ada Youk; F Nicole McCarthy; Stephanie Davis; David J Keljo; Athos Bousvaros; Diane Fairclough; David Kupfer; Daniel J Buysse; Eva M Szigethy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

Review 10.  Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Laura M Mackner; Rachel Neff Greenley; Eva Szigethy; Michele Herzer; Kate Deer; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-04       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.